 |
 |

Intraepidermal Nerve Fiber Densities in Chronic Inflammatory Autoimmune Diseases
Lasse G. Gøransson, MD;
Johan G. Brun, MD, PhD;
Erna Harboe, MD;
Svein I. Mellgren, MD, PhD;
Roald Omdal, MD, PhD
Arch Neurol. 2006;63:1410-1413.
Background Some patients with systemic lupus erythematosus have selective loss of small-diameter nerve fibers, while larger nerve fibers are unaffected.
Objective To determine intraepidermal nerve fiber densities in patients with different chronic inflammatory autoimmune diseases.
Design Cross-sectional study.
Setting Stavanger University Hospital, Stavanger, and Haukeland University Hospital, Haukeland, Norway.
Patients Sixty patients with systemic lupus erythematosus (SLE) (mean ± SD age, 43.2 ± 13.5 years), 61 patients with primary Sjögren syndrome (age, 57.1 ± 14.7 years), and 52 patients with rheumatoid arthritis (age, 57.4 ± 12.3 years) were compared with 106 healthy subjects (age, 49.0 ± 19.6 years).
Interventions Skin biopsy specimens.
Main Outcome Measures To evaluate small-diameter nerve fiber loss, intraepidermal nerve fiber densities were measured in skin punch biopsy specimens obtained from the distal part of the leg.
Results The mean ± SD densities were 7.5 ± 3.8 fibers/mm in patients with SLE, 9.2 ± 3.8 fibers/mm in primary Sjögren syndrome, and 10.9 ± 5.4 fibers/mm in rheumatoid arthritis vs 12.4 ± 4.6 fibers/mm in healthy subjects. Densities were significantly less in patients with SLE vs patients with rheumatoid arthritis and vs healthy subjects (P<.001 for both), as well as in patients with primary Sjögren syndrome vs healthy subjects (P<.001). Eight patients (13%) with SLE, 2 patients (3%) with primary Sjögren syndrome, and 2 patients (4%) with rheumatoid arthritis had densities below the lower reference limit of 3.4 fibers/mm, consistent with small-diameter nerve fiber neuropathy.
Conclusion The degree of loss of small-diameter nerve fibers differs among patients with these chronic inflammatory autoimmune diseases, likely reflecting differences in pathogenesis and organ affinity of the individual disease entities.
Author Affiliations: Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger (Drs Gøransson, Harboe, and Omdal); Institute of Internal Medicine (Drs Gøransson and Omdal) and Section of Rheumatology, Institute of Medicine (Dr Brun), University of Bergen, Bergen; Department of Rheumatology, Haukeland University Hospital, Haukeland (Dr Brun); and Institute of Clinical Medicine, University of Tromsø, and Department of Neurology, University Hospital of North Norway, Tromsø (Dr Mellgren), Norway.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Peripheral Neuropathy in Primary Sjogren Syndrome: A Population-Based Study
Goransson et al.
Arch Neurol 2006;63:1612-1615.
ABSTRACT
| FULL TEXT
|